Search Results - "Oinonen, Michael J."

Antifungal use in hospitalized adults in U.S. academic health centers by Pakyz, Amy L, Gurgle, Holly E, Oinonen, Michael J

“…Use of antifungal agents and predictors of total antifungal use among adult inpatients at U.S. academic health centers was characterized. Claims data obtained…”
Get full text

Trends in Antibacterial Use in Hospitalized Pediatric Patients in United States Academic Health Centers by Pakyz, Amy L., Gurgle, Holly E., Ibrahim, Omar M., Oinonen, Michael J., Polk, Ronald E.

“…Trends in pediatric antibacterial use were examined in 20 academic health centers during the period 2002–2007. There was a significant increase in the use of…”
Get full text

Fluoroquinolone use and fluoroquinolone-resistant Pseudomonas aeruginosa is declining in US academic medical centre hospitals by Pakyz, Amy L, Lee, Jin A, Ababneh, Mera A, Harpe, Spencer E, Oinonen, Michael J, Polk, Ron E

Get full text

Characterization of Continued Antibacterial Therapy After Diagnosis of Hospital-Onset Clostridium difficile Infection: Implications for Antimicrobial Stewardship by Harpe, Spencer E., Inocencio, Timothy J., Pakyz, Amy L., Oinonen, Michael J., Polk, Ronald E.

“…Study Objectives To determine the proportion of hospitalized adults with hospital‐onset Clostridium difficile infection (CDI) who continued to receive…”
Get full text

Outcomes Associated with Vasoactive Therapy in Patients with Acute Decompensated Heart Failure by Arnold, Lindsay M., Crouch, Michael A., Carroll, Norman V, Oinonen, Michael J.

“…Study Objectives. To describe the clinical management of acute decompensated heart failure (ADHF) in patients receiving intravenous treatment with dobutamine,…”
Get full text

The power of collaboration: using internet-based tools to facilitate networking and benchmarking within a consortium of academic health centers by Korner, Eli J, Oinonen, Michael J, Browne, Robert C

“…The University HealthSystem Consortium (UHC) represents a strategic alliance of 169 academic health centers and associated institutions engaged in knowledge…”
Get full text

Characterization of Continued Antibacterial Therapy After Diagnosis of Hospital‐Onset C lostridium difficile Infection: Implications for Antimicrobial Stewardship by Harpe, Spencer E., Inocencio, Timothy J., Pakyz, Amy L., Oinonen, Michael J., Polk, Ronald E.

Get full text

Characterization of Continued Antibacterial Therapy After Diagnosis of Hospital-Onset Clostridium difficile Infection: Implications for Antimicrobial Stewardship : ANTIMICROBIAL STEWARDSHIP by HARPE, Spencer E, INOCENCIO, Timothy J, PAKYZ, Amy L, OINONEN, Michael J, POLK, Ronald E

Get full text

1040-73 Financial impact of drug-eluting stents: The US academic experience by Marks, David S, Ratko, Thomas A, Matuszewski, Karl A, Oinonen, Michael J, Cummings, Joseph P

Get full text

1020-68 Utility of an online clinical database for tracking innovative technology: The academic drug-eluting stent experience by Marks, David Scott, Ratko, Thomas A, Matuszewski, Karl A, Oinonen, Michael J, Cummings, Joseph P

Get full text

How do academic health centers value and encourage clinical research? by Oinonen, M J, Crowley, Jr, W F, Moskowitz, J, Vlasses, P H

“…To investigate whether there is a misalignment of the perceived values of and incentives for clinical research within U.S. academic health centers (AHCs), in…”
Get full text

Clinical and Economic Outcomes of Coronary Angioplasty Alone or in Combination with Stents in Academic Health Centers: A Retrospective Database Analysis by Oinonen, Michael J., Akhras, Kasem S., Chen, Connie, Matuszewski, Karl A., Vlasses, Peter H.

“…Indications for the use of stents are evolving and their optimal place in therapy remains to be defined. The objective was to compare the 1-year clinical and…”
Get full text

National data sources on the care and outcomes of patients with community acquired pneumonia by Oinonen, M J, Sansguiri, V, Smith, M

“…Despite improved understanding and treatment of community acquired pneumonia (CAP), variations in clinical practice and patient outcomes still exists,…”
Get full text

Epoetin Alfa for Dialysis Outpatients: Analysis of Administered versus Medicare-Reimbursed Units by Oinonen, Michael J., Chen, Connie, Danekas, Lynne H., Matuszewski, Karl A., Vlasses, Peter H.

“…This study audited the efficiency and accuracy of patient billing and reimbursement systems for epoetin alfa (Epo). The outpatient records of 604 chronic…”
Get full text